Terra Nova Asset Management LLC Decreases Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Terra Nova Asset Management LLC cut its stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 12.5% during the 1st quarter, HoldingsChannel reports. The firm owned 1,413 shares of the company’s stock after selling 202 shares during the quarter. Terra Nova Asset Management LLC’s holdings in HCA Healthcare were worth $488,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Atwood & Palmer Inc. purchased a new stake in shares of HCA Healthcare during the first quarter valued at approximately $28,000. Whipplewood Advisors LLC purchased a new position in HCA Healthcare in the 4th quarter valued at about $31,000. Tidemark LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter worth about $36,000. ORG Partners LLC grew its stake in HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company’s stock valued at $38,000 after purchasing an additional 86 shares in the last quarter. Finally, Legacy Investment Solutions LLC raised its position in shares of HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company’s stock valued at $62,000 after purchasing an additional 95 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Baird R W cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Monday, April 28th. Morgan Stanley set a $410.00 target price on HCA Healthcare and gave the stock an “equal weight” rating in a report on Monday, June 9th. Stephens raised shares of HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Finally, Guggenheim began coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating for the company. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $394.33.

View Our Latest Stock Report on HCA Healthcare

HCA Healthcare Stock Performance

HCA stock opened at $373.81 on Thursday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a market capitalization of $89.93 billion, a P/E ratio of 16.62, a PEG ratio of 1.31 and a beta of 1.49. The company has a 50-day simple moving average of $364.79 and a 200 day simple moving average of $335.92. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCAGet Free Report) last released its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts’ consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. During the same period in the prior year, the firm posted $5.36 earnings per share. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.77%. HCA Healthcare’s dividend payout ratio is currently 12.81%.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer now owns 12,646 shares of the company’s stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.